TLR4 Cancer Research Results
TLR4, Toll-like receptor 4: Click to Expand ⟱
| Source: |
| Type: |
Also called CD284 (cluster of differentiation 284)
A key activator of the innate immune response and plays a central role in the fight against bacterial infections.
Accumulating evidences demonstrated that the activation of TLR4 in tumor microenvironment can not only boost the anti-tumor immunity but also give rise to immune surveillance and tumor progression. "double-edged sword” role of TLR4 activation
|
BC, Breast Cancer: Click to Expand ⟱
Scientific Papers found: Click to Expand⟱
| - |
in-vitro, |
BC, |
MCF-7 |
|
|
|
- |
in-vitro, |
BC, |
MDA-MB-231 |
|
|
|
TLR4↓, IRF3↓, IFN-γ↓, TRIF↓,
| - |
in-vitro, |
BC, |
MDA-MB-231 |
|
|
|
TumCP↓, TumCMig↓, TumCI↓, MMP↓, TLR4↓, TNF-α↓, NF-kB↓, IL1β↓, IL6↓, IRAK4↓, GLUT1↓, GLUT3↓, HK2↓, PFK↓, PKM2↓, LDHA↓, ACC↓, FASN↓, eff↓,
ChemoSen↓, RadioS↑, Inflam↓, AntiCan↑, Dose∅, mtDam↑, Apoptosis?, OCR↓, ATP↓, ROS↑, ROS↑, LDH↓, TP53↓, Casp3↓, BAX↓, P21↓, ROS↑, eNOS↑, iNOS↑, eff↑, hTERT/TERT↓, cycD1/CCND1↓, eff↑, eff↑, eff↑, eff↑, STAT3↓, TIMP1↓, IL4↓, IL10↓, OS↑, Dose∅, ER Stress↑, ROS↑, NF-kB↓, p65↓, MMP↓, TumAuto↑, LC3II↑, p62↓, TLR4↓, mtDam↑, LDH↓, ROS↑, Glycolysis↓, HK2↓, PFK↓, PKM2↓, LDH↓, IL10↓, HDAC8↓, eff↑, eff↑, P21↑,
Showing Research Papers: 1 to 3 of 3
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 3
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress ⓘ
ROS↑, 5,
Mitochondria & Bioenergetics ⓘ
ATP↓, 1, MMP↓, 2, mtDam↑, 2, OCR↓, 1,
Core Metabolism/Glycolysis ⓘ
ACC↓, 1, FASN↓, 1, Glycolysis↓, 1, HK2↓, 2, LDH↓, 3, LDHA↓, 1, PFK↓, 2, PKM2↓, 2,
Cell Death ⓘ
Apoptosis?, 1, BAX↓, 1, Casp3↓, 1, hTERT/TERT↓, 1, iNOS↑, 1,
Protein Folding & ER Stress ⓘ
ER Stress↑, 1,
Autophagy & Lysosomes ⓘ
LC3II↑, 1, p62↓, 1, TumAuto↑, 1,
DNA Damage & Repair ⓘ
TP53↓, 1,
Cell Cycle & Senescence ⓘ
cycD1/CCND1↓, 1, P21↓, 1, P21↑, 1,
Proliferation, Differentiation & Cell State ⓘ
HDAC8↓, 1, STAT3↓, 1,
Migration ⓘ
TIMP1↓, 1, TumCI↓, 1, TumCMig↓, 1, TumCP↓, 1,
Angiogenesis & Vasculature ⓘ
eNOS↑, 1,
Barriers & Transport ⓘ
GLUT1↓, 1, GLUT3↓, 1,
Immune & Inflammatory Signaling ⓘ
IFN-γ↓, 1, IL10↓, 2, IL1β↓, 1, IL4↓, 1, IL6↓, 1, Inflam↓, 1, IRAK4↓, 1, NF-kB↓, 2, p65↓, 1, TLR4↓, 3, TNF-α↓, 1, TRIF↓, 1,
Drug Metabolism & Resistance ⓘ
ChemoSen↓, 1, Dose∅, 2, eff↓, 1, eff↑, 7, RadioS↑, 1,
Clinical Biomarkers ⓘ
hTERT/TERT↓, 1, IL6↓, 1, LDH↓, 3, TP53↓, 1,
Functional Outcomes ⓘ
AntiCan↑, 1, OS↑, 1,
Infection & Microbiome ⓘ
IRF3↓, 1,
Total Targets: 59
Pathway results for Effect on Normal Cells:
Total Targets: 0
Scientific Paper Hit Count for: TLR4, Toll-like receptor 4
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:4 Cells:% prod#:% Target#:559 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid
Home Page